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• Cancer registry data
– Women aged 15-99 diagnosed with breast cancer
– Australia and England (1990-1994)  
– New South Wales and West Midlands (1980-2002)
• Patient demographics, tumour characteristics 
• Ecological deprivation scores (unemployment)
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• Survival higher in New South Wales and 
Australia
• Deprivation ‘gap’ wider in West Midlands
• Survival much lower among elderly in West 
Midlands than New South Wales




• International & socio-economic differences 
not fully explained by extent of disease
• No effect of age or histology




























• deprivation X region
• age group X region
• extent of disease X region
































• deprivation X region
• age group X region
• extent of disease X region























2nd-5th years after diagnosis
Model includes:
• deprivation X region
• age group X region
• extent of disease X region
































• deprivation X region
• age group X region
• extent of disease X region
• year of diagnosis
• histological group
Some causal explanations
• Delay in diagnosis – patient or system
• Treatment – type, delivery, compliance
• Nutritional status, co-morbidity
Conclusions
• Breast cancer survival differences exist
• Unlikely to be artefact
• May be treatment-related
• May also be partly related to delay 
(patient, healthcare system)
